piperidine has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aimone, LD; Albom, MS; Angeles, TS; Ator, MA; Cheng, M; Dorsey, BD; Haltiwanger, RC; Huang, Z; Kordwitz, E; Landis, AJ; Lu, L; Mesaros, EF; Olsen, M; Ott, GR; Ruggeri, BA; Wagner, JC; Wan, W | 1 |
1 other study(ies) available for piperidine and Lymphoma, Large-Cell, Anaplastic
Article | Year |
---|---|
Piperidine-3,4-diol and piperidine-3-ol derivatives of pyrrolo[2,1-f][1,2,4]triazine as inhibitors of anaplastic lymphoma kinase.
Topics: Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Cell Line, Tumor; Crystallography, X-Ray; Humans; Lymphoma, Large-Cell, Anaplastic; Mice, SCID; Models, Molecular; Piperidines; Protein Kinase Inhibitors; Pyrroles; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Triazines | 2015 |